Neurotrophic factors in the pathogenesis of Rett syndrome.
Rett syndrome is characterized by disruption of a period of vigorous brain growth with synapse development. Neurotrophic factors are important regulators of neuronal growth, differentiation, and survival during early brain development. The aims of this study were to study the role of neurotrophic factors in Rett syndrome, specifically whether Rett syndrome has abnormal levels of specific neurotrophic factors in serum and cerebrospinal fluid and whether the changes differ from other neuropediatric patients, for example, those with infantile autism. Four neurotrophic factors were measured: nerve growth factor, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, and insulin-like growth factor 1 from the frozen cerebrospinal fluid and from serum (except glial cell line-derived neurotrophic factor) by enzyme-linked immunosorbent assay and cerebrospinal fluid glutamate and aspartate by high-performance liquid chromatography (HPLC) method in patients with Rett syndrome. Insulin-like growth factor 1 was measured from the cerebrospinal fluid of patients with infantile autism. We found low concentrations of cerebrospinal fluid nerve growth factor in patients with Rett syndrome compared with control patients. The serum levels and other cerebrospinal fluid neurotrophic factor levels of the patients did not differ from the controls. Patients with Rett syndrome had high cerebrospinal fluid glutamate levels. Patients with infantile autism had low cerebrospinal fluid insulin-like growth factor 1 levels. Nerve growth factor acts especially on cholinergic neurons of the basal forebrain, whereas insulin-like growth factor 1 acts on cerebellar neurons. In Rett syndrome, the forebrain is more severely affected than the other cortical areas. In autism, many studies show hippocampal or cerebellar pathology. Our findings are in agreement with the different morphologic and neurochemical findings (brain growth, affected brain areas, neurotransmitter metabolism) in the two syndromes. Impairment in dendritic development in Rett syndrome could be the consequence of cholinergic deficiency and of neurotrophic factor/glutamate imbalance. Cholinergic gene expression might be influenced by the Rett syndrome gene directly or via the neurotrophic factor system.
Riikonen
Raili
R
Department of Child Neurology, The Children's Hospital, University of Kuopio, Kuopio, Finland. raili.riikonen@uku.fi
D000293:Adolescent; D001224:Aspartic Acid / Q000134:cerebrospinal fluid; D001321:Autistic Disorder / Q000134:cerebrospinal fluid*; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D002851:Chromatography, High Pressure Liquid; D004797:Enzyme-Linked Immunosorbent Assay; D018846:Excitatory Amino Acids / Q000134:cerebrospinal fluid*; D051100:Glial Cell Line-Derived Neurotrophic Factor; D018698:Glutamic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D020932:Nerve Growth Factor / Q000378:metabolism; D009414:Nerve Growth Factors / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D015518:Rett Syndrome / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*
D019208:Brain-Derived Neurotrophic Factor; D018846:Excitatory Amino Acids; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D001224:Aspartic Acid; D018698:Glutamic Acid; D007334:Insulin-Like Growth Factor I; D020932:Nerve Growth Factor